“We are delighted to welcome Shameze to our team during this important time in TransEnterix’s journey,” TransEnterix CEo Anthony Fernando said in a news release. “His extensive experience at implementing financial strategies and sourcing equity and debt financing options will be invaluable as we continue towards our goals for 2020 and beyond. I am confident Shameze will make an immediate positive impact on the organization and help lead TransEnterix through its next phase of growth.”
Rampertab has over 20 years of financial leadership experience in the healthcare sector. He also spent time as an investment banker and sell-side equity research analyst. Most recently, he rose up to become interim CEO at animal health company Zomedica Pharmaceuticals.
TransEnterix recently reported tough but better-than-expected results for its second quarter as it navigates a challenging COVID-19 pandemic environment.